RN7SL474P

Across TCGA pan-cancer cohorts, RN7SL474P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL474P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SL474P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL474P expression acts as an unfavorable survival marker.

BRCA, ESCA, and SKCM are the cancer types where RN7SL474P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	III,IV	0.699	0.912	.012	48	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
SKCM	DFS	Tertile	III,IV	0.027	0.602	<.001	18	view →
KIRC	DFS	Tertile	IV	0.266	0.616	.019	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
LUSC	OS	Tertile	II,III,IV	0.181	0.686	.011	18	view →
HNSC	OS	Tertile	All	0.191	0.710	.021	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL474P–BRCA (OS)

Open the BRCA breakdown →